Cargando…
Bryostatin‐1 ameliorated experimental colitis in Il‐10 (−/−) Mice by protecting the intestinal barrier and limiting immune dysfunction
Bryostatin‐1 (Bry‐1) has been proven to be effective and safe in clinical trials of a variety of immune‐related diseases. However, little is known about its effect on Crohn's disease (CD). We aimed to investigate the impact of Bry‐1 on CD‐like colitis and determine the mechanism underlying this...
| Autores principales: | , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
John Wiley and Sons Inc.
2019
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6652299/ https://www.ncbi.nlm.nih.gov/pubmed/31251471 http://dx.doi.org/10.1111/jcmm.14457 |